NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION

Size: px
Start display at page:

Download "NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACTIVASE (t-pa) INFUSION PROTOCOL FOR ACUTE MYOCARDIAL INFARCTION"

Transcription

1 NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACTIVASE (t-pa) FOR ACUTE MYOCARDIAL INFARCTION I. PURPOSE: A. To reduce the extent of myocardial infarction by lysing the clot in the coronary artery, salvaging the myocardium and preserving ventricular function. B. To reduce morbidity and mortality in acute myocardial infarction. II. PATIENT SELECTION: A. The patient must manifest the clinical signs and symptoms of acute myocardial infarction including typical electrocardiographic changes of acute injury. III. CONTRAINDICATIONS: A. Uncontrolled hypertension with systolic blood pressure of more than 180 mmhg, diastolic blood pressure of more than 110 mmhg. B. Recent CVA, intracranial neoplasm, AV malformation and aneurysm. C. Recent (within two months) intracranial or spinal injury, trauma or surgery. D. Pregnancy Date of Original: 1/85 Reviewed Revised 3/97 3/08 3/08 10/1 10/10 9/11 9/11 9/ /14 10/15 10/16 6/17 17

2 t-pa (ACTIVASE) E. Contraindication to anticoagulation. 1. Active internal bleeding including G.I., G.U. bleed, dissecting aortic aneurysm. 2. Bleeding diathesis. 3. Recent (within ten days) trauma or major surgery, including coronary artery bypass surgery, intra-abdominal surgery, organ biopsy, obstetrical delivery, prolonged traumatic external cardiac compression, traumatic endotracheal intubation, etc. IV. RELATIVE CONTRAINDICATIONS: A. Recent puncture of non-compressible blood vessel, i.e., subclavian vein, etc. B. Advanced liver and kidney disease. C. Infectious endocarditis. D. Pericarditis. E. Known or high likelihood of left heart thrombus. F. Diabetic hemorrhagic retinopathy or other hemorrhagic ophthalmic conditions. G. Septic thrombophlebitis or occluded AV cannula at seriously infected site. H. Patients currently receiving oral anticoagulants, i.e., warfarin sodium. I. Active peptic ulcer disease. V. PROCEDURE: A. The patient and/or patient s family should be well informed by the physician of the potential complications of acute thrombolytic therapy including bleeding complications. B. I.V. t-pa should be infused as soon as possible after the diagnosis of acute myocardial infarction is established. Any physician may prescribe I.V. t-pa, however, a cardiology consultation is recommended. 17a

3 C. Initial diagnostic work-up (STAT): 1. CBC and differential 2. Protime and PTT 3. Thrombin time 4. Fibrinogen 5. Blood typing 6. Routine CCU lab 7. EKG on admission and immediately before the procedure. D. Insert two peripheral venous lines in different arms, one in a large peripheral vein for I.V. t-pa infusion, the other for infusion of drugs. A separate heparin lock will be inserted for blood sampling. E. Patient may be given Lidocaine at the discretion of the physician. F. I.V. t-pa administration: Follow reconstitution directions for 100 mg dose vial. 1. Accelerated dose: For patients weighing more than 67kg: 15mg/BOLUS (15cc over 1-2 min.) 50mg/30 min. (Rate 100cc/hr, volume to be infused = 50mg) 35mg/60 min. (Rate 35cc/hr, volume to be infused = 35 mg) TOTAL: 100 mg/90 min. (t-pa I.V. bolus may be given by R.N.) 17b

4 2. Accelerated dose: For patients weighing less than 67 kg: 15 mg BOLUS mg/kg/30 min mg/kg/60 min.) See scale below. WGT. IN LBS. WGT. IN KGS. 15 MG. BOLUS TOTAL MG. FOR MAINTEN- ANCE 0.75 MG/KG 20 MIN INF RATE 0.5 MG/KG 60 MIN INF RATE TOTAL DOSE Up ml. 52 mg. 54 mg. 57 mg. 60 mg. 63 mg. 65 mg. 68 mg. 71 mg. 73 mg. 76 mg. 80 mg. 83 mg. 84 mg. 85 mg. 85 mg. 62 ml/hr 64 ml/hr 68 ml/hr 72 ml/hr 75 ml/hr 78 ml/hr 82 ml/hr 86 ml/hr 88 ml/hr 92 ml/hr 96 ml/hr 99 ml/hr 21 ml/hr 22 ml/hr 23 ml/hr 23 ml/hr 25 ml/hr 26 ml/hr 27 ml/hr 28 ml/hr 29 ml/hr 30 ml/hr 32 ml/hr 33 ml/hr 34 ml/hr 35 ml/hr 35 ml/hr 67 mg. 69 mg. 72 mg. 75 mg. 78 mg. 80 mg. 83 mg. 86 mg. 88 mg. 91 mg. 95 mg. 98 mg. 99 mg. 100 mg. 100 mg. G. Administration of I.V. Heparin with I.V. t-pa infusion is recommended. The dosage of Heparin to be given is at the discretion of the Physician. The suggested dose of Heparin is 5,000 units I.V. bolus (given concurrently with the t-pa) followed by 1,000 units per hour with subsequent dose adjustments to maintain PTT seconds. I.V. heparin is recommended for at least 48 hours. (Heparin must be given through a separate I.V. site than Activase). H. Hold all venipuncture sites for at least five minutes. I. Test all stools for occult blood. H & H and PTT should be checked q 6 hours for at least 24 hours or at the discretion of the physician. J. Strict bed rest for 24 hours. 17c

5 K. Blood pressure should be monitored at least every 15 minutes during t-pa administration and the patient should be observed carefully for bleeding complications. L. Follow strict anticoagulation precaution protocol. 17d

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS I. Purpose : A. To reduce morbidity and mortality associated

More information

ACCESS CENTER:

ACCESS CENTER: ACCESS CENTER: 1-877-367-8855 Emergency Specialty Services: BRAIN ATTACK Criteria: Stroke symptom onset time less than 6 hours Referring Emergency Department Patient Information Data: Time last known normal:

More information

CLINICAL GUIDELINES ID TAG

CLINICAL GUIDELINES ID TAG Title: Author: Speciality/ Division: Directorate: Date Uploaded: Review Date: September 2019 CG ID TAG CG0423 CLINICAL GUIDELINES ID TAG Clinical Guideline for Alteplase in intra-arterial thrombolysis

More information

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer:

Primary Stroke Center Acute Stroke Transfer Guidelines When to Consider a Transfer: When to Consider a Transfer: Hemorrhagic Stroke Large volume intracerebral hematoma greater than 5cm on CT Concern for expanding hematoma Rapidly declining mental status, especially requiring intubation

More information

How to give thrombolysis in acute myocardial infarction

How to give thrombolysis in acute myocardial infarction Page 1 of 6 How to give thrombolysis in acute myocardial infarction Original article: Michael Tam In the major urban hospitals, there will be little place for thrombolysis in acute STEMI (STelevation myocardial

More information

Management of Acute Myocardial Infarction

Management of Acute Myocardial Infarction Management of Acute Myocardial Infarction Prof. Hossam Kandil Professor of Cardiology Cairo University ST Elevation Acute Myocardial Infarction Aims Of Management Emergency care (Pre-hospital) Early care

More information

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE S EPTIFIBATIDE (INTEGRILIN) I. PURPOSE: A. Integrilin (Eptifibatide) is a specific and potent inhibitor of the platelet receptor glycoprotein

More information

ST Elevated Myocardial Infarction- Latest AHA recommendations

ST Elevated Myocardial Infarction- Latest AHA recommendations ST Elevated Myocardial Infarction- Latest AHA recommendations Sherry Turner, DO, MPH, FACOEP Medical Director Emergency Services Wesley Medical Center The Problem 250,000 Americans each year 30% fail to

More information

Is Thrombolysis Only for a Crisis?

Is Thrombolysis Only for a Crisis? Is Thrombolysis Only for a Crisis? December 19, 2017 Is Thrombolysis Only for a Crisis? Indications for Thrombolytic Therapy in Patients with Acute Pulmonary Embolism Case Scenario A 28 year old woman

More information

9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case

9/24/2013. Thrombolytics in 2013: Never Say Never. September 19 th, 2013 Scott M Lilly, MD PhD. Clinical Case September 19 th, 2013 Scott M Lilly, MD PhD Thrombolytics in 2013: Never Say Never Clinical Case 2 1 Evolution of STEMI Therapy The importance of absolute rest in bed for several days is clear James B

More information

When the learner has completed this module, she/he will be able to:

When the learner has completed this module, she/he will be able to: Thrombolytics and Myocardial Infarction WWW.RN.ORG Reviewed September 2017, Expires September 2019 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2017

More information

ASSESS OPPORTUNITIES TO IDENTIFY MISSED ELIGIBLE PATIENTS KEY QUESTIONS TO CONSIDER What are the top reasons for non-treatment? Are patients excluded

ASSESS OPPORTUNITIES TO IDENTIFY MISSED ELIGIBLE PATIENTS KEY QUESTIONS TO CONSIDER What are the top reasons for non-treatment? Are patients excluded Identifying Missed Eligible AIS Patients Indication Activase (alteplase) is indicated for the treatment of acute ischemic stroke (AIS). Exclude intracranial hemorrhage as the primary cause of stroke signs

More information

Thrombolysis administration

Thrombolysis administration Thrombolysis administration Liz Mackey Stroke Nurse Practitioner Western Health Sunshine & Footscray Hospital, Melbourne Thanks ASNEN committee members Skye Coote, Acute Stroke Nurse, Eastern Health (slide

More information

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE

GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE 2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American

More information

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS:

* * FORM REV. 02/2019 Page 1 of 4. TNKASE (tenecteplase) / ACUTE STEMI ORDERS SCHEDULED MEDICATIONS: 1. Is this a CMS inpatient only procedure? Yes, admit as inpatient, proceed to # 3 No, proceed to # 2 2. Do you expect that the patient s condition will require a hospital stay that will cross two midnights

More information

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08)

Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08) Thrombolysis for acute ischaemic stroke Rapid Assessment Protocol NORTHERN IRELAND Regional Protocol (Version 002 July 08) Patient Details Time of onset? Capillary Blood glucose 2.8-22.2 mmol/l? Blood

More information

Nursing Process Focus: Patients Receiving Heparin

Nursing Process Focus: Patients Receiving Heparin Obtain complete heath history including allergies, drug history and possible drug Assess baseline coagulation studies and CBC. Assess for history of bleeding disorders, GI bleeding, cerebral bleed, recent

More information

Alliance A Symptomatic brain radionecrosis after receiving radiosurgery for

Alliance A Symptomatic brain radionecrosis after receiving radiosurgery for RANDOMIZED PHASE II STUDY: CORTICOSTEROIDS + BEVACIZUMAB VS. CORTICOSTEROIDS + PLACEBO (BEST) FOR RADIONECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES Pre-registration Eligibility Criteria Required Initial

More information

o Unenhanced Head CT

o Unenhanced Head CT Drip & Ship Protocol Acute Stroke Ready Hospital (ASRH) Duluth Area Primary Stroke Center (St. Luke s & St. Mary s Essentia) PATIENT LABEL Patient displays strokelike symptoms EMS/ED CSS > 0 Glucose >

More information

Nitroglycerin and Heparin Drip Interfacility Protocols

Nitroglycerin and Heparin Drip Interfacility Protocols Nitroglycerin and Heparin Drip Interfacility Protocols EMS Protocol This protocol applies to nitroglycerin and Heparin drips that are initiated at the transferring facility prior to transport and are not

More information

Diagnosis and Management of Acute Myocardial Infarction

Diagnosis and Management of Acute Myocardial Infarction Diagnosis and Management of Acute Myocardial Infarction Acute Myocardial Infarction (AMI) occurs as a result of prolonged myocardial ischemia Atherosclerosis leads to endothelial rupture or erosion that

More information

BEAUMONT HOSPITAL. Beaumont Hospital Department of Nephrology and Renal Nursing ADMINISTRATION OF ACTILYSE. Guideline Number: 13. Guideline Version: B

BEAUMONT HOSPITAL. Beaumont Hospital Department of Nephrology and Renal Nursing ADMINISTRATION OF ACTILYSE. Guideline Number: 13. Guideline Version: B BEAUMONT HOSPITAL Beaumont Hospital Department of Nephrology and Renal Nursing Guideline Name: GUIDELINES FOR THE ADMINISTRATION OF ACTILYSE Guideline Number: 13 Guideline Version: B Developed By: Betty

More information

Protocol for IV rtpa Treatment of Acute Ischemic Stroke

Protocol for IV rtpa Treatment of Acute Ischemic Stroke Protocol for IV rtpa Treatment of Acute Ischemic Stroke Acute stroke management is progressing very rapidly. Our team offers several options for acute stroke therapy, including endovascular therapy and

More information

Considering Activase (alteplase) for treatment of acute ischemic stroke

Considering Activase (alteplase) for treatment of acute ischemic stroke Considering Activase (alteplase) for treatment of acute ischemic stroke A DISCUSSION GUIDE FOR PATIENTS AND CAREGIVERS Indication Activase (alteplase) is indicated for treating patients with acute ischemic

More information

Thrombolysis Assessment

Thrombolysis Assessment Thrombolysis Assessment Brief Clinical Summary of symptom onset of arrival of patient of assessment BP GCS BM If BM

More information

ED Stroke Panel Page 1 of 2

ED Stroke Panel Page 1 of 2 ED Stroke Panel Page 1 of 2 Reference EMMC *************************Usec: Call Operator to page a Stroke Alert ********************** Laboratory Bedside Glucose Monitoring ONCE Notify provider if glucose

More information

The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial

The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial The Multi arm Optimization of Stroke Thrombolysis (MOST) Trial Study Team Principal Investigators: Opeolu Adeoye, University of Cincinnati (Lead) Andrew Barreto, University of Texas Houston Jim Grotta,

More information

RETAVASE (reteplase) for injection, for intravenous use Initial U.S. Approval: 1996

RETAVASE (reteplase) for injection, for intravenous use Initial U.S. Approval: 1996 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RETAVASE safely and effectively. See full prescribing information for RETAVASE. RETAVASE (reteplase)

More information

ADVERSE REACTIONS The most frequently occurring adverse reaction ( > 5%) is bleeding.

ADVERSE REACTIONS The most frequently occurring adverse reaction ( > 5%) is bleeding. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ACTIVASE safely and effectively. See full prescribing information for ACTIVASE. Activase (alteplase)

More information

Routine, Every 2 hours, Starting today, If temperature greater than 38.5 C initiate Evaluation for Possible Sepsis Physician Order #829

Routine, Every 2 hours, Starting today, If temperature greater than 38.5 C initiate Evaluation for Possible Sepsis Physician Order #829 Height Weight Allergies General Vital Signs [X] Frequent vital signs Indication: Q15 minutes x (# of occurrences): 4 Q30 minutes x (# of occurrences): 4 Q1 hour x (# of occurrences): Q2 hours x (# of occurrences):

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

Objectives. Treatment of ACS. Early Invasive Strategy. UA/NSTEMI General Concepts. UA/NSTEMI Initial Therapy/Antithrombotic

Objectives. Treatment of ACS. Early Invasive Strategy. UA/NSTEMI General Concepts. UA/NSTEMI Initial Therapy/Antithrombotic Objectives Treatment of ACS Michael P. Gulseth, Pharm. D., BCPS Pharmacotherapy II Spring 2006 Define early invasive strategy and what patients typically receive this approach Compare/contrast the medications

More information

Primary Stroke Center Quality & Performance Measures

Primary Stroke Center Quality & Performance Measures Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition

More information

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION Page 1 Legend: BOLD = Required ^ = MLL Data Element Admin (Tab) ^Patient ID: Physician/Provider NPI: DOB: / / ^Arrival Date/Time: Race: Hispanic

More information

Critical Review Form Therapy

Critical Review Form Therapy Critical Review Form Therapy Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion Lancet 1993; 341:501-511 Objective: To determine

More information

PE Pathway. The charts are listed as follows:

PE Pathway. The charts are listed as follows: PE Pathway This document comprises 6 simple flow charts to assist clinicians in the investigation and treatment of suspected or confirmed Acute Pulmonary Emboli. The pathway has been put together using

More information

Results of Ischemic Heart Disease

Results of Ischemic Heart Disease Ischemic Heart Disease: Angina and Myocardial Infarction Ischemic heart disease; syndromes causing an imbalance between myocardial oxygen demand and supply (inadequate myocardial blood flow) related to

More information

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!! Thrombolytic therapy should be the first line treatment in acute ishchemic stroke We are against it!! 85% of strokes are ischaemic, and related to blockage of an artery by a blood clot, so potential treatments

More information

Administering Intravenous Alteplase (Tissue Plasminogen Activator [tpa])

Administering Intravenous Alteplase (Tissue Plasminogen Activator [tpa]) Administering Intravenous Alteplase (Tissue Plasminogen Activator [tpa]) Step 1: Eligibility---The eligibility criteria for patients with acute ischemic stroke within 3 hours of symptom onset include:

More information

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents

Chapter 10 Worksheet Blood Pressure and Antithrombotic Agents Complete the following. 1. A layer of cells lines each vessel in the vascular system. This layer is a passive barrier that keeps cells and proteins from going into tissues; it also contains substances

More information

Activase (alteplase) for injection, for intravenous use Initial U.S. Approval: RECENT MAJOR CHANGES

Activase (alteplase) for injection, for intravenous use Initial U.S. Approval: RECENT MAJOR CHANGES Guidelines for Achieving Door-to-Needle in 60 Minutes or Less Indication Activase (alteplase) is indicated for the treatment of acute ischemic stroke (AIS). Exclude intracranial hemorrhage as the primary

More information

Acute Stroke Protocols Modified- What s New in 2013

Acute Stroke Protocols Modified- What s New in 2013 Acute Stroke Protocols Modified- What s New in 2013 KUMAR RAJAMANI, MD, DM. Vascular Neurologist-MSN Associate Professor of Neurology WSU School of Medicine. Saturday, September 21, 2013 Crystal Mountain

More information

Resident Teaching Conference 3/12/2010

Resident Teaching Conference 3/12/2010 Resident Teaching Conference 3/12/2010 Goals Definition and Classification of Acute Limb Ischemia Clinical Assessment of the Vascular Patient History and Physical Diagnostic Modalities Management of Acute

More information

METALYSE Tenecteplase

METALYSE Tenecteplase METALYSE Tenecteplase Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Metalyse. It does not contain all the available information. It does not take

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Tenecteplase Boehringer Ingelheim Pharma KG 6,000 units Powder and solvent for solution for injection 2. QUALITATIVE AND QUANTITATIVE

More information

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4 TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Transfer to: 10 South Attending Physician: Diagnosis:

More information

P-RMS: LT/H/PSUR/0004/001

P-RMS: LT/H/PSUR/0004/001 Core Safety Profile Active substance: Dalteparine Pharmaceutical form(s)/strength: Solution for injection, 2500 I.U./0.2ml, 2500 I.U./ml, 5000 I.U./0.2ml, 7500 I.U./0.3ml, 7500 I.U./0.75ml, 10000 I.U./0.4ml,

More information

2019 Home Hemodialysis Standing Orders

2019 Home Hemodialysis Standing Orders 2019 Home Hemodialysis Standing Orders 1. Nutrition Standards of Care: A. Follow P&P Nutrition Standards of Care 2. Laboratory Tests: A. Drawn On Admission: 1. Renal Function Panel (BMP, PO 4 and Albumin)

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control

More information

Problems with Cardiac and Tissue Perfusion

Problems with Cardiac and Tissue Perfusion Problems with Cardiac and Tissue Perfusion Review anatomy and physiology Identify ECG Echocardiogram TEE Persantine Thallium Coronary angiogram Discuss etiology, pathophsiology, clinical manifestation,

More information

Emergency Department Management of Acute Ischemic Stroke

Emergency Department Management of Acute Ischemic Stroke Emergency Department Management of Acute Ischemic Stroke R. Jason Thurman, MD Associate Professor of Emergency Medicine and Neurosurgery Associate Director, Vanderbilt Stroke Center Vanderbilt University,

More information

Inhixa (Enoxaparin Sodium)

Inhixa (Enoxaparin Sodium) Inhixa (Enoxaparin Sodium) P R E V ENTIS SAFETY D E V I C E P R E V E N T I S I S A N AU TO M AT I C N E E D L E S H I E L D I N G S Y S T E M, W H I C H H A S A C O V E R T H AT E X T E N D S O V E R

More information

2018 Early Management of Acute Ischemic Stroke Guidelines Update

2018 Early Management of Acute Ischemic Stroke Guidelines Update 2018 Early Management of Acute Ischemic Stroke Guidelines Update Brandi Bowman, PhC, Pharm.D. April 17, 2018 Pharmacist Objectives Describe the recommendations for emergency medical services and hospital

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Morillo CA, Verma A, Connolly SJ, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): a randomzied clinical

More information

Present-on-Admission (POA) Coding

Present-on-Admission (POA) Coding 1 Present-on-Admission (POA) Coding Michael Pine, MD, MBA Michael Pine and Associates, Inc 2 POA and Coding Guidelines (1) Unless otherwise specified, a POA modifier must be assigned to each principal

More information

VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017

VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017 VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017 VTE IS THE 2 ND MOST COMMON HOSPITAL ACQUIRED CONDITION RISK FACTORS DECREASED ACTIVITY = VTE RISK (NURSES MEASURE WITH BRADEN

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS IV 1. NAME OF THE MEDICINAL PRODUCT AGGRASTAT/AGRASTAT * concentrate for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of concentrate

More information

IR Central Venous Access [ ] Pre Procedure

IR Central Venous Access [ ] Pre Procedure IR Central Venous Access [1050200001] Pre Procedure Case Request/Scheduling Procedure Enter IR Case Request if not already completed (All hospitals except Grant Medical Center) [ ] Case Request IR Lab

More information

Section 6 Intra Aortic Balloon Pump

Section 6 Intra Aortic Balloon Pump Section 6 Intra Aortic Balloon Pump The Intra Aortic Balloon Pump (IABP) The balloon is synthetic and is made for single use only. It is threaded into the aorta, usually via a femoral approach. The balloon

More information

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs (family hotel, drive back to the VA for next day pick up)

More information

The first 24 hours are critical when Activase (alteplase) is administered 1-3

The first 24 hours are critical when Activase (alteplase) is administered 1-3 FOR YOUR ACUTE ISCHEMIC STROKE PATIENTS The first 24 hours are critical when Activase (alteplase) is administered 1-3 Close observation and frequent monitoring of patients for neurological changes, any

More information

Thrombolysis in Acute Myocardial Infarction

Thrombolysis in Acute Myocardial Infarction CHAPTER 70 Thrombolysis in Acute Myocardial Infarction J. S. Hiremath Introduction Reperfusion of the occluded coronary artery at the earliest is the most important aim of management of STEMI. Once a flow

More information

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy) DRUG GUIDELINE HYDRALAZINE (Intravenous severe hypertension SCOPE (Area): FOR USE IN: Labour Ward, HDU, Theatre and ED EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other general wards. SCOPE

More information

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1)

Canadian Stroke Best Practices Initial ED Evaluation of Acute Stroke and Transient Ischemic Attack (TIA) Order Set (Order Set 1) Canadian Best Practice Recommendations for Stroke Care: All patients presenting to an emergency department with suspected stroke or transient ischemic attack must have an immediate clinical evaluation

More information

Emergency Treatment of Ischemic Stroke

Emergency Treatment of Ischemic Stroke Emergency Treatment of Ischemic Stroke JEFFREY BOYLE, M.D., PHD CLINICAL DIRECTOR OF STROKE AT AVERA MCKENNAN AVERA MEDICAL GROUP NEUROLOGY SIOUX FALLS, SD Conflicts of Interest None I will discuss therapies

More information

After a stroke starts

After a stroke starts After a stroke starts What you need to know about clot-busting therapy What happens during a stroke When brain cells do not get the oxygen-carrying blood that they need to function, they begin to die.

More information

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข

Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Emergency start at community level: Prehospital care Acute stroke

More information

Disclosures. Outline. Updated Recommendations for Using Alteplase (TPA) in Acute Ischemic Stroke

Disclosures. Outline. Updated Recommendations for Using Alteplase (TPA) in Acute Ischemic Stroke Updated Recommendations for Using Alteplase (TPA) in Acute Ischemic Stroke Mark J. Alberts, MD, FAHA Chief of Neurology Hartford Hospital Hartford, CT Disclosures Dr. Alberts is a speaker and consultant

More information

Policy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016

Policy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016 Title: Antihypertensive Treatment for Severe Hypertension During Pregnancy Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016 Policy POLICY STATEMENT: Pregnant or postpartum patients

More information

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior

More information

convey the clinical quality measure's title, number, owner/developer and contact

convey the clinical quality measure's title, number, owner/developer and contact CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical

More information

VTE Prophylaxis. NEW NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients

VTE Prophylaxis. NEW NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients NEW NICE guidance NICE guidance (MTG19) supports the use of the geko device for people who have a high risk of VTE and for whom pharmacological or other mechanical methods of VTE prevention are impractical

More information

Link between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis.

Link between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis. Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention Rabah M, Mason D, Muller D W, Hundley R, Kugelmass

More information

Using an anti-xa level nomogram to adjust intravenous unfractionated heparin infusion for arrhythmia in pregnancy

Using an anti-xa level nomogram to adjust intravenous unfractionated heparin infusion for arrhythmia in pregnancy Using an anti-xa level nomogram to adjust intravenous unfractionated heparin infusion for arrhythmia in pregnancy W. Sia, E. Toor, N. Wahab, J. Windram, R. Khurana Cardiac Problems in Pregnancy Congress

More information

BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine

BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine BC Cancer Protocol Summary for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine Protocol Code Tumour Group Contact Physician UGOOVBEVV Gynecologic Oncology Dr.

More information

Complications of Acute Myocardial Infarction

Complications of Acute Myocardial Infarction Acute Myocardial Infarction Complications of Acute Myocardial Infarction Diagnosis and Treatment JMAJ 45(4): 149 154, 2002 Hiroshi NONOGI Director, Division of Cardiology and Emergency Medicine, National

More information

Acute Coronary Syndrome

Acute Coronary Syndrome ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to

More information

Special Article. on Thrombolytic Therapy in Thrombosis,

Special Article. on Thrombolytic Therapy in Thrombosis, 17 Special Article Thrombolytic Therapy in Thrombosis NATIONAL INSTITUTES OF HEALTH A NATIONAL INSTITUTES OF HEALTH Consensus Development Conference, held at NIH April 10-12, 1980, addressed the issue

More information

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT

More information

Thrombolysis, adjunctive pharmacology and interventions

Thrombolysis, adjunctive pharmacology and interventions ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation ESC Annual Congress Munich, 2012 Thrombolysis, adjunctive pharmacology and interventions

More information

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date: Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY TNKase (Tenecteplase) DESCRIPTION TNKase (Tenecteplase) is a tissue plasminogen activator (tpa) produced by recombinant DNA technology using an established mammalian cell line (Chinese Hamster Ovary cells).

More information

Pathophysiology of stroke

Pathophysiology of stroke A practical approach to acute stro ke Dr. Sanjith Aaron, M.D., D.M., Professor, Department of Neurosciences, CMC Vellore Stroke is characterized by an abrupt onset of neurological deficit lasting more

More information

It is what you will see most in practice and what you need to know thoroughly.

It is what you will see most in practice and what you need to know thoroughly. Acute Myocardial Infarction: Pre-hospital Issues 2 CEUs By: Michelle E. Duffelmeyer, MD INTRODUCTION An in depth review of the pathophysiology, symptomatology, and treatment modalities for acute MI. It

More information

Recent Changes in IV TPA Recommendations. Ashish Masih, M.D Vascular Neurology

Recent Changes in IV TPA Recommendations. Ashish Masih, M.D Vascular Neurology Recent Changes in IV TPA Recommendations Ashish Masih, M.D Vascular Neurology Disclosures none 4 th leading cause of death Nearly 800,000 cases of stroke annually Statistics Leading cause of disability

More information

Myocardial infarction

Myocardial infarction CHAPTER-I CARDIOVASCULAR SYSTEM Myocardial infarction SUB: PHARMACOTHERAPEUTICS-I CODE:T0820006 Dr. Venugopal Pharm.D Assistant Professor Department of Pharm.D Kriahna Teja Pharmacy College,Tirupati. Definition

More information

2.5 Other Hematology Consult:

2.5 Other Hematology Consult: The Warfarin Order Sheet has been approved by the P & T committee to be implemented by pharmacists. These orders are not used to treat patients with serious hemorrhagic complications. WARFARIN TARGET INR

More information

Orthopedic Admission Hip Fracture Version 2 1/25/2017

Orthopedic Admission Hip Fracture Version 2 1/25/2017 Patient Name: Initial each page and Sign/Date/Time last page Diagnosis: Allergies with reaction type: Orthopedic Admission Hip Fracture Version 2 1/25/2017 Patient Placement Patient Status If the physician

More information

Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests. CBC, Electrolytes, Urea, Creatinine, Glucose, INR, PTT, Urinalysis

Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests. CBC, Electrolytes, Urea, Creatinine, Glucose, INR, PTT, Urinalysis of nurse 1. Admit under ward Attending Physician: Dr. Admit date (YYYY/MM/DD): Cardiologist On-Call: Diagnosis: Lab Tests 2. On admission (if not already performed in Emergency Department or in Coronary

More information

Warfarin - Introduction for New Users

Warfarin - Introduction for New Users Warfarin - Introduction for New Users Introduction Blood clots are frequent in patients who have diseases of the blood vessels or heart. Blood clots may pose a dangerous threat to some people, as they

More information

NUH Emergency Department. Guideline for Diagnosis & Treatment of PE (Massive and Non-Massive) in Adults only

NUH Emergency Department. Guideline for Diagnosis & Treatment of PE (Massive and Non-Massive) in Adults only NUH Emergency Department Guideline for Diagnosis & Treatment of PE (Massive and n-massive) in Adults only Contents Suspected Pulmonary Embolus in the ED Flow Chart Page 1 Administration of Thrombolysis

More information

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date: Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 02.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital

Dr Ben Turner. Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Stroke Management Dr Ben Turner Consultant Neurologist and Honorary Senior Lecturer Barts and The London NHS Trust London Bridge Hospital Introduction Stroke is the major cause of disability in the developed

More information

Epidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic

Epidemiology: Incidence VTE: Mortality  Morbidity Risk Factors: Acute Chronic : Genetic Submassive PE Pulmonary Embolism Epidemiology: Incidence VTE: 100-200/100,000 = 3rd most frequent cardiovascular disease Symptomatic DVT complicated by PE = 40-50% Sudden fatal PE = 34% Intermediate-risk

More information

Chp. 5 The cardiovascular system. What are the function of the cardiovascular system? Arteries and arterioles:

Chp. 5 The cardiovascular system. What are the function of the cardiovascular system? Arteries and arterioles: 5.1 Overview of the cardiovascular system Chp. 5 The cardiovascular system Includes the heart and blood vessels Brings nutrients to cells and helps get rid of wastes Blood is refreshed in the lung, kidneys,

More information

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals

University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals Goals Learn to coordinate a variety of data from multiple cardiovascular sub-disciplines, e.g. catheterization laboratory, hemodynamic study, non-invasive imaging, nuclear, electrophysiologic, and in combination

More information

Standardize comprehensive care of the patient with severe traumatic brain injury

Standardize comprehensive care of the patient with severe traumatic brain injury Trauma Center Practice Management Guideline Iowa Methodist Medical Center Des Moines Management of Patients with Severe Traumatic Brain Injury (GCS < 9) ADULT Practice Management Guideline Contact: Trauma

More information